Pharmacorp Rx enters deal to acquire pharmacy files

Executive Summary

• Pharmacorp Rx Inc. has entered into a non-binding letter of intent (LOI) to acquire the prescription files, patient records, and related operational data of a pharmacy in Western Canada.
• The acquisition targets specific operational assets (files and data) rather than the corporate entity or physical fixtures, with closing expected in Q1 2026.
• The transaction is part of Pharmacorp’s national consolidation strategy to enhance operational efficiency and patient care continuity.

Key Details

• Transaction Type: Non-binding Letter of Intent (LOI) for asset acquisition.
• Target Assets: Prescription files, patient records, and related operational data of a pharmacy in Western Canada.
• Target Location: Same community as an existing PharmaCorp "PharmaChoice-bannered" pharmacy.
• Purchase Price: Anticipated $350,000, subject to customary adjustments.
• Payment Method: Cash on hand.
• Closing Timeline: Expected during the first quarter of 2026.
• Fees: No finders' fees payable.
• Exclusions: The acquisition does not include the target's corporate entity, fixtures, or other operating assets.
• Post-Closing Operations: Patient files will be transferred to and serviced by Pharmacorp's existing pharmacy in the community.
• Conditions Precedent: Execution of a definitive agreement, satisfactory due diligence, and customary representations, warranties, indemnities, and covenants.
• Strategic Context: Part of a national consolidation strategy focusing on scalable opportunities that complement the existing pharmacy footprint.

Notable Quotes

• "This transaction reflects our disciplined approach to growth and our commitment to strengthening patient care in the communities we serve," said Alan Simpson, executive chair of the board of Pharmacorp. "By integrating these pharmacy files into our existing pharmacy, we can enhance operational efficiency while ensuring continuity of care for local residents."